“SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF ABEMACICLIB IN THE TREATMENT OF HR+ HER2− ADVANCED OR METASTATIC BREAST CANCER ”. 2026. Vietnam Journal of Community Medicine 67 (10). https://doi.org/10.52163/yhc.v67i10.6967.